Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parainfluenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Early research (Phase 1)Study completedNCT04144348
What this trial is testing

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 51
Not applicableUnknownNCT04099082
What this trial is testing

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans

Who this might be right for
Allogeneic Hematopoietic Stem Cell RecipientsAcute Respiratory InfectionParainfluenza Virus (PIV)
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Study completedNCT01644877
What this trial is testing

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 111
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01254175
What this trial is testing

Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children

Who this might be right for
Parainfluenza Virus 3, Human
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Looking for participantsNCT03808922
What this trial is testing

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Who this might be right for
Lower Respiratory Tract InfectionParainfluenzaImmunocompromised+1 more
Ansun Biopharma, Inc. 274
Early research (Phase 1)Study completedNCT04954287
What this trial is testing

Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents

Who this might be right for
Covid19
CyanVac LLC 72
Early research (Phase 1)Study completedNCT00641017
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine

Who this might be right for
ParainfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Testing effectiveness (Phase 2)Ended earlyNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 11
Not applicableStudy completedNCT02984280
What this trial is testing

Specific Respiratory Infections as Triggers of Acute Medical Events

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus InfectionsParainfluenza+4 more
University College, London 787,000
Early research (Phase 1)Study completedNCT01139437
What this trial is testing

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Who this might be right for
Human Parainfluenza Virus 2
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Early research (Phase 1)Study completedNCT03392389
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 124
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272